detail content area
Stem Cells, 2019. 37, 1130-1135, DOI: https://doi.org/10.1002/stem.3003
A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017
Jung-Hyun Kim, Alex Alderton; Jeremy M. Crook; Nissim Bevenisty; Catharina Brandsten; Meri Firpo; Peter W. Harrison; Shin Kawamata; Eihachiro Kawase; Andreas Kurtz; Jeanne F. Loring; Tenneille Ludwig; Jennifer Man; Joanne C. Mountford; Marc L. Turner; Steve Oh; Lygia Da Veiga Pereira; Patricia Pranke; Michael Sheldon; Rachel Steeg; Stephen Sullivan; Michael Yaffe; Qi Zhou; Glyn N. Stacey
This report summarizes the recent activity of the International Stem Cell Banking Initiative held at Harvard Stem Cell Institute, Boston, MA, USA, on June 18, 2017. In this meeting, we aimed to find consensus on ongoing issues of quality control (QC), safety, and efficacy of human pluripotent stem cell banks and their derivative cell therapy products for the global harmonization. In particular, assays for the QC testing such as pluripotency assays test and general QC testing criteria were intensively discussed. Moreover, the recent activities of global stem cell banking centers and the regulatory bodies were briefly summarized to provide an overview on global developments and issues.
- DOI: https://doi.org/10.1002/stem.3003
- ISBN or ISSN: 1066-5099
- 본 연구는 질병관리본부 연구개발과제연구비를 지원받아 수행되었습니다.
- This research was supported by a fund by Research of Korea Centers for Disease Control and Prevention.